TREATMENT WITH THE HUMANIZED CD154-SPECIFIC MONOCLONAL ANTIBODY, hu5C8, PREVENTS ACUTE REJECTION OF PRIMARY SKIN ALLOGRAFTS IN NONHUMAN PRIMATES1 - Concepedia

Concepedia

Publication | Closed Access

TREATMENT WITH THE HUMANIZED CD154-SPECIFIC MONOCLONAL ANTIBODY, hu5C8, PREVENTS ACUTE REJECTION OF PRIMARY SKIN ALLOGRAFTS IN NONHUMAN PRIMATES1

98

Citations

20

References

2001

Year

Eric A. Elster, He Xu, Douglas K. Tadaki, Sean P. Montgomery, Linda C. Burkly, Justin D. Berning, Roxanne E. Baumgartner, Frank Cruzata, Richard S. Marx, David M. Harlan,

Transplantation

Abstract

These results show that treatment with the CD154-specific monoclonal antibody, hu5C8, greatly delays the onset of acute skin allograft rejection.

References

	Year	Citations

Page 1